In 2021 we have established development units in Germany with the development of an operational headquarter in Mainz. Our development units include laboratories for MEMS & Sensor Research and Sensor Evaluation and Validation. The structure of our laboratories is adapted to facilitate and support streamlined clinical testing.
Based on strategic acquisitions, increased IP confirmations and broadened academic cooperation’s throughout, Lifecare is positioned to enlarge the scope of use for the basic Sencell technology to include a wide range of measurements for use in medical and professional environments, as well as lifestyle driven point-of-care measurements.
Lifecare work with acknowledged research and development partners across Europe.
The research and development is performed through our research partners across Europe. Our partners are all rated global experts in their field.
Lifecare has a close collaboration with the University of Bath, UK for further development of the chemical composition for use in Sencell. The chemical composition is a core part of the technology and forms the basis for accurate, reliable and immediate measurement of glucose. The university is well renowned and established as a top 10 UK university what a reputation for research and teaching excellence.
Pfützner Science & Health Institute is Lifecare’s development partner and responsible for carrying out our R&D activities. The institute is globally acknowledged for their comprehensive services for designing and conducting clinical studies.
University of Bath
Research at the University of Bath is improving lives and changing the world we live in.
- Ranked 6th in the UK by the Guardian University Guide 2020
- Awarded Gold in the Teaching Excellence Framework 2017
- 87% of our research is classed as world-leading or internationally excellent by the most recent Research Excellence Framework 2014
PFÜTZNER Science & Health Institute
PFÜTZNER Science & Health Institute deliver research at the highest level, incl
- Centre for clinical studies (phases II – IV)
- Centre for medicinal/medical product studies (incl. CE studies)
- Laboratory studies pursuant to ISO15197:2013 for blood glucose monitoring systems
- Performance/preference studies for medical products
- Strategy and performance of clinical investigations